These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
534 related articles for article (PubMed ID: 19892250)
41. Antimicrobial resistance: factors and outcomes. Fish DN; Ohlinger MJ Crit Care Clin; 2006 Apr; 22(2):291-311, vii. PubMed ID: 16678001 [TBL] [Abstract][Full Text] [Related]
42. The management of severe sepsis and septic shock. Morrell MR; Micek ST; Kollef MH Infect Dis Clin North Am; 2009 Sep; 23(3):485-501. PubMed ID: 19665079 [TBL] [Abstract][Full Text] [Related]
43. [Evaluation of justification for antibiotic use at the Internal Medicine Clinic of the Clinical Hospital in Zagreb]. Erdeljić V; Francetić I; Macolić Sarinić V; Bilusić M; Huić M; Merćep I; Makar-Ausperger K Acta Med Croatica; 2004; 58(4):293-9. PubMed ID: 15700685 [TBL] [Abstract][Full Text] [Related]
44. Antibiotic therapy for gram-negative bacteremia. Calandra T; Cometta A Infect Dis Clin North Am; 1991 Dec; 5(4):817-34. PubMed ID: 1783770 [TBL] [Abstract][Full Text] [Related]
45. Clinical implications of antibiotic-induced endotoxin release in septic shock. Lepper PM; Held TK; Schneider EM; Bölke E; Gerlach H; Trautmann M Intensive Care Med; 2002 Jul; 28(7):824-33. PubMed ID: 12122518 [TBL] [Abstract][Full Text] [Related]
46. Antibiotic combinations for the empiric treatment of the febrile neutropenic patient. Walsh TJ; Schimpff SC Schweiz Med Wochenschr Suppl; 1983; 14():58-63. PubMed ID: 6361993 [TBL] [Abstract][Full Text] [Related]
47. [New antibiotics for severe sepsis--the break-through?]. Burgmann H Dtsch Med Wochenschr; 2008 Feb; 133(8):372-3. PubMed ID: 18270921 [No Abstract] [Full Text] [Related]
49. [Infection and septic shock. Antibiotic therapy]. Lode H Verh Dtsch Ges Inn Med; 1987; 93():349-53. PubMed ID: 3442112 [No Abstract] [Full Text] [Related]
50. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Gaieski DF; Mikkelsen ME; Band RA; Pines JM; Massone R; Furia FF; Shofer FS; Goyal M Crit Care Med; 2010 Apr; 38(4):1045-53. PubMed ID: 20048677 [TBL] [Abstract][Full Text] [Related]
51. Considerations for Empiric Antimicrobial Therapy in Sepsis and Septic Shock in an Era of Antimicrobial Resistance. Strich JR; Heil EL; Masur H J Infect Dis; 2020 Jul; 222(Suppl 2):S119-S131. PubMed ID: 32691833 [TBL] [Abstract][Full Text] [Related]
52. Rational use of aminoglycosides--review and recommendations by the Swedish Reference Group for Antibiotics (SRGA). Hanberger H; Edlund C; Furebring M; G Giske C; Melhus A; Nilsson LE; Petersson J; Sjölin J; Ternhag A; Werner M; Eliasson E; Scand J Infect Dis; 2013 Mar; 45(3):161-75. PubMed ID: 23270477 [TBL] [Abstract][Full Text] [Related]
53. Overview of antimicrobial therapy in intensive care units. Textoris J; Wiramus S; Martin C; Leone M Expert Rev Anti Infect Ther; 2011 Jan; 9(1):97-109. PubMed ID: 21171881 [TBL] [Abstract][Full Text] [Related]
54. Preface: optimizing antimicrobial therapy of sepsis and septic shock. Kumar A Crit Care Clin; 2011 Jan; 27(1):xi-xii. PubMed ID: 21144982 [No Abstract] [Full Text] [Related]
55. Empiric Antibiotic Therapy of Nosocomial Bacterial Infections. Reddy P Am J Ther; 2016; 23(4):e982-94. PubMed ID: 24413366 [TBL] [Abstract][Full Text] [Related]
56. Mono- or combination antibiotic therapy for septic shock? An epistemological dilemma. Corona A Crit Care Med; 2011 Feb; 39(2):423-4; author reply 424-5. PubMed ID: 21248539 [No Abstract] [Full Text] [Related]
57. [An effect of continuous and intermittent renal replacement therapy on antibiotic treatment in critically ill patients with sepsis - a practice-based perspective of vancomycin and gentamycin therapies]. Petejová N; Martínek A; Zahálková J; Duricová J; Plášek J; Valkovský I; Grundmann M; Kacířová I Vnitr Lek; 2012 Jun; 58(6):448-54. PubMed ID: 22913237 [TBL] [Abstract][Full Text] [Related]
58. Antibiotic Stewardship: Strategies to Minimize Antibiotic Resistance While Maximizing Antibiotic Effectiveness. Cunha CB; Opal SM Med Clin North Am; 2018 Sep; 102(5):831-843. PubMed ID: 30126574 [TBL] [Abstract][Full Text] [Related]
59. Antibiotic Use in the Intensive Care Unit: Optimization and De-Escalation. Campion M; Scully G J Intensive Care Med; 2018 Dec; 33(12):647-655. PubMed ID: 29534630 [TBL] [Abstract][Full Text] [Related]